Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zymeworks Inc (NY: ZYME ) N/A UNCHANGED Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zymeworks Inc < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Bitcoin Futures Arrive October 19, 2021 Today you can finally hold Bitcoins via an exchange-traded fund. Via Talk Markets Chinese Growth Level October 18, 2021 The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues. Via Talk Markets Europe's Unicorns October 15, 2021 After markets jumped yesterday, we saw a lot of bounce today although gold fell back a bit. Via Talk Markets Markets Boosted October 07, 2021 Good news helped stock prices. Via Talk Markets Perfumes Of Arabia October 06, 2021 Downtrends do eventually run out of pessimistic steam, but it can take a while. Via Talk Markets Sweet Smell Of Recovery October 05, 2021 Markets today saw many reversals of moves by ADR companies in the course of the day, mainly because of macro changes. Via Talk Markets Zymeworks and ALX Oncology Announce First Patient Dosed in Phase 1b/2 Clinical Trial of Zanidatamab and Evorpacept (ALX148) in Patients with Advanced HER2-Expressing Breast Cancer and Other Solid Tumors October 05, 2021 From Zymeworks Inc. Via Business Wire October Starts Positive October 01, 2021 A lot of these moves are simply reactions to last month's excesses and they may not be predictive for October at all. Via Talk Markets Multiple Bits Of Bad News September 28, 2021 Republican debt ceiling brinkmanship boosted yields way over what stocks can pay, with info-tech the big loser. Via Talk Markets Zymeworks' Zanidatamab Aces Mid-Stage Esophageal Cancer Trial September 16, 2021 At the European Society of Medical Oncology Congress 2021 (ESMO21), Zymeworks Inc (NYSE: ZYME) presented encouraging early data on its HER2‑targeted bispecific antibody. Twenty-... Via Benzinga Zanidatamab Phase 2 Clinical Trial Demonstrates Promising Response Rate and Durability in First-Line HER2-Positive Gastroesophageal Adenocarcinoma (GEA) at the European Society for Medical Oncology (ESMO) Annual Congress September 16, 2021 From Zymeworks Inc. Via Business Wire Pressure Day September 13, 2021 Today a recovery came to markets with a particular impact on uranium shares. Via Talk Markets Zymeworks Announces Abstract for Zanidatamab in First-line HER2-Expressing Gastroesophageal Cancers (GEA) at the European Society for Medical Oncology (ESMO) Annual Congress September 12, 2021 From Zymeworks Inc. Via Business Wire Delta Variant Fears Continue September 09, 2021 The jobless level fell to 310,000 whereas the consensus forecast was for 335,000, so risks of inflation are higher. Via Talk Markets The Real World August 11, 2021 The rise of the delta has caused markets to drop back after the rises earlier although inflation still remains within a point or two of forecasts at 5.3-5.4% annualized. Via Talk Markets Delta Outbreak August 04, 2021 The US market was droopy because of poor private sector jobless numbers. Via Talk Markets Zymeworks Reports 2021 Second Quarter Financial Results August 04, 2021 From Zymeworks Inc. Via Business Wire Markets: COVID Is Back August 03, 2021 BP Plc reported earnings beats of 22 cents with a Q2 eps of 83 cents. Schlumberger Ltd, normally supported by French descendants from the founding Alsatian brothers, was hit by concern about the price... Via Talk Markets Topics Earnings Exposures Financial Zymeworks Announces Milestone Payment as Janssen Achieves First Patient Dosed for its Bispecific Antibody Utilizing Zymeworks’ Azymetric™ and EFECT™ Therapeutic Platforms August 03, 2021 From Zymeworks Inc. Via Business Wire Zymeworks Announces First Patient with Advanced HER2-Positive Breast Cancer Dosed with Zanidatamab in Combination with Tukysa® (Tucatinib) and Chemotherapy July 28, 2021 From Zymeworks Inc. Via Business Wire Banned Merger July 27, 2021 Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood. Via Talk Markets Chinese Stock Crash July 26, 2021 For a second week in a row, we saw a big drop in stocks on Monday, while the Delta virus variant was blamed for the selloff last week, this week the cause is a big Beijing regulatory crackdown on... Via Talk Markets Delta Defeats Bulls July 19, 2021 Stocks tended to crash without rhyme or reason. Via Talk Markets Weak Week July 16, 2021 Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism. Via Talk Markets Powell Talks Some More July 15, 2021 Another day, another sell-off. Via Talk Markets Dialing For Stocks July 14, 2021 Thanks to Fed Chairman Powell, markets brushed off worrying about inflation today. Via Talk Markets Topics Economy Exposures Interest Rates Recovery Friday July 09, 2021 The big winners this week were Financials. Via Talk Markets Zymeworks to Present at Ladenburg Thalmann Healthcare Conference July 08, 2021 From Zymeworks Inc. Via Business Wire Fireworks Display July 05, 2021 The oil price rose to 76.81/bbl after the OPEC attempt to have a meeting to agree to boost production (and cut prices) was blocked. Via Talk Markets People Needed July 02, 2021 If qualified people are not looking for work, they will have to be lured to do so with higher wages. Via Talk Markets Exposures Labor < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.